(19)

(11)

EP 4 469 080 A2

(12)

(88) Date of publication A3: 31.08.2023 (43) Date of publication: 04.12.2024 Bulletin 2024/49 (21) Application number: 23708311.8 (22) Date of filing: 27.01.2023

(51) International Patent Classification (IPC):  A61K 39/12(2006.01) A61P 31/14(2006.01) A61K 39/215(2006.01) C07K 14/005(2006.01) (52) Cooperative Patent Classification (CPC): A61K 39/12; A61P 31/14; C07K 14/005; C12N 2770/20022; C12N 2770/20034 (86) International application number: PCT/US2023/011791 (87) International publication number: WO 2023/147092 (03.08.2023 Gazette 2023/31)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 28.01.2022 US 202263304560 P 05.07.2022 US 202263358523 P 09.08.2022 US 202263396580 P 18.01.2023 US 202363480375 P (71) Applicants: BioNTech SE 55131 Mainz (DE) Pfizer Inc. New York, NY 10001-2192 (US)

(72) Inventors: CHE, Ye Groton, Connecticut 06340 (US) SWANSON, Kena Anne Middletown Road Pearl River, New York 10965 (US) (74) Representative: Schnappauf, Georg  ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München 80686 München (DE)